At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 29 enrolled
Drug / intervention
Maintenance chemotherapy +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Maintenance Chemotherapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Chemotherapy for Stage IV Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II Trial
University of Texas Southwestern Medical Center·interventional·Posted Jan 24, 2014·Updated May 23, 2023
In Brief
A Phase 2 clinical trial evaluating Stereotactic Body Radiation Therapy and Maintenance chemotherapy for Stage IV Non-Small Cell Lung Cancer. Completed, enrolled 29 participants across 1 site.
Detailed Summary
The core hypothesis to be tested is that the use of consolidative SBRT followed by maintenance chemotherapy in patients with less than or equal to 6 metastatic sites (primary + 5) will improve progression free survival (PFS) compared to maintenance chemotherapy alone.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStage IV Non-Small Cell Lung Cancer
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJan 2014
Enrollment StartFeb 2014
Primary CompletionFeb 2022
Study CompletionMay 2022
TodayJul 2026
First PostedJan 24, 2014
Enrollment StartFeb 1, 2014
Primary CompletionFeb 17, 2022
Study CompletionMay 2, 2022
TodayJul 2, 2026
Enrollment to primary: 8.0 yearsPosted 12.4 years ago
Interventions
Stereotactic Body Radiation Therapyradiation
Maintenance chemotherapydrug
Maintenance chemotherapy